MAX BioPharma's Grant

MAX BioPharma raised a round of funding on October 07, 2013. Investors include National Institutes of Health.

MAX BioPharma is a start up biopharmaceutical company engaged in discovery and development of small molecules to target human disorders including non-healing bone fractures, osteoporosis, and cancer. …

Articles about MAX BioPharma's Grant: